The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.

NCT04393493 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Cardiorenal Syndrome

Interventions

DRUG: Furosemide intravenous solution
DRUG: Chlortalidone
DRUG: Spironolactone

Sponsor

Hospital Civil de Guadalajara